Gene · 3598
Papers2,877
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
381 to 400 of 2,877
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Spotlights on adult patients with pediatric-type diffuse gliomas in accordance with the 2021 WHO classification of CNS tumors. | Front Neurosci | 2023 | 37214395 | PubTator, text mining | PubMed |
| Targeted treatment of solid tumors in pediatric precision oncology. | Front Oncol | 2023 | 37213274 | PubTator, text mining | PubMed |
| Biomimetic nanotherapeutics for targeted drug delivery to glioblastoma multiforme. | Bioeng Transl Med | 2023 | 37206213 | PubTator, text mining | PubMed |
| Gut Microbiome and Metabonomic Profile Predict Early Remission to Anti-Integrin Therapy in Patients with Moderate to Severe Ulcerative Colitis. | Microbiol Spectr | 2023 | 37199618 | PubTator, text mining | PubMed |
| Precision medicine and drug optimization in adult inflammatory bowel disease patients. | Ther Adv Gastroenterol | 2023 | 37197397 | PubTator, text mining | PubMed |
| Human endogenous retrovirus onco-exaptation counters cancer cell senescence through calbindin. | J Clin Invest | 2023 | 37192000 | PubTator, text mining | PubMed |
| Spatially Guided and Single Cell Tools to Map the Microenvironment in Cutaneous T-Cell Lymphoma. | Cancers (Basel) | 2023 | 37190290 | PubTator, text mining | PubMed |
| Gene Targets of CAR-T Cell Therapy for Glioblastoma. | Cancers (Basel) | 2023 | 37190280 | PubTator, text mining | PubMed |
| Dupilumab in Inflammatory Skin Diseases: A Systematic Review. | Biomolecules | 2023 | 37189381 | PubTator, text mining | PubMed |
| The Current Status and Future Perspectives of Chimeric Antigen Receptor-Engineered T Cell Therapy for the Management of Patients with Endometrial Cancer. | Curr Issues Mol Biol | 2023 | 37185744 | PubTator, text mining | PubMed |
Do Elevated YKL-40 Levels Drive the Immunosuppressive Tumor Microenvironment in Colorectal Cancer? Assessment of the Association of the Expression of YKL-40, MMP-8, IL17A, and PD-L1 with Coexisting Type 2 Diabetes, Obesity, and Active Smoking. | Curr Issues Mol Biol | 2023 | 37185706 | PubTator, text mining | PubMed |
| Role of Fibroblasts in Chronic Inflammatory Signalling in Chronic Rhinosinusitis with Nasal Polyps-A Systematic Review. | J Clin Med | 2023 | 37176721 | PubTator, text mining | PubMed |
| Interleukins (Cytokines) as Biomarkers in Colorectal Cancer: Progression, Detection, and Monitoring. | J Clin Med | 2023 | 37176567 | PubTator, text mining | PubMed |
| Reshaping the Pancreatic Cancer Microenvironment at Different Stages with Chemotherapy. | Cancers (Basel) | 2023 | 37173915 | PubTator, text mining | PubMed |
| CAR T cell-based immunotherapy and radiation therapy: potential, promises and risks. | Mol Cancer | 2023 | 37173782 | PubTator, text mining | PubMed |
| Anoikis-related genes combined with single cell sequencing: Insights into model specification of lung adenocarcinoma and applicability for prognosis and therapy. | Front Cell Dev Biol | 2023 | 37169018 | PubTator, text mining | PubMed |
| Myeloid-specific deletion of chitinase-3-like 1 protein ameliorates murine diet-induced steatohepatitis progression. | J Mol Med (Berl) | 2023 | 37166517 | PubTator, text mining | PubMed |
| Advanced immunotherapies for glioblastoma: tumor neoantigen vaccines in combination with immunomodulators. | Acta Neuropathol Commun | 2023 | 37165457 | PubTator, text mining | PubMed |
| Cellular Therapy for Children with Central Nervous System Tumors: Mining and Mapping the Correlative Data. | Curr Oncol Rep | 2023 | 37160547 | PubTator, text mining | PubMed |
| Expression of IL-13Rα2 and FUS in glioma: clinicopathological and prognostic correlation. | BMC Neurol | 2023 | 37158824 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3598/papers?page=20